Mesalamine inactive ingredients by manufacturer
Wondering whether your Mesalamine has lactose, gluten, soy, a dye or gelatin in it? The medicine is the same, but the fillers, coatings and colors differ from one company to the next. This page shows what each Mesalamine product's FDA label lists, so you can find a version that leaves out what you avoid and ask your pharmacist for it by its NDC.
We have read the FDA labels of 59 of the 67 current Mesalamine products on the market today, from 39 companies listing it with the FDA, and lined them up side by side. 7 are still being read and will appear on a later visit. 1 label has no inactive-ingredient list we could read, so that product cannot be compared.
Ask about your bottle
Is there something in your Mesalamine? Ask in plain words.
Name the company, strength or the NDC on your bottle and the ingredient you avoid. The answer comes only from the FDA labels on this page.
Answers are drawn from the FDA label data on this page and checked against it. They are not medical advice: confirm with your pharmacist before relying on them.
The short answer
Which Mesalamine products list lactose, a gluten source, soy, dyes or gelatin?
-
LactoseDiffers by manufacturer
5 of 59 checked products list lactose; 54 do not. See the products
Does not list it Actavis Alembic Pharmaceuticals Inc. Alembic Pharmaceuticals Limited Allergan American Health Packaging Amring ANI Ascend Aurobindo AvPAK Bryant Ranch Prepack Camber Chartwell RX Encube Ethicals Golden State Medical Supply Ingenus KLM Laboratories Private Lannett Major Mylan NorthStar RxLLC Nuvaila Padagis Israel Rising Salix Sandoz Sun Pharmaceutical Industries, Inc. Sun Pharmaceutical Industries Inc. Takeda Teva Pharmaceuticals USA, Inc. Upsher-Smith Viatris Specialty Zydus Zydus Lifesciences -
Wheat or gluten sourceNo checked product
No checked Mesalamine product lists a wheat or gluten source.
-
SoyNo checked product
No checked Mesalamine product lists soy.
-
Synthetic dyesDiffers by manufacturer
19 of 59 checked products list synthetic dyes; 40 do not. See the products
Does not list it Actavis Allergan American Health Packaging Amneal Amring ANI Bryant Ranch Prepack Camber Chartwell RX Encube Ethicals Golden State Medical Supply KLM Laboratories Private Lannett Major NorthStar RxLLC Nuvaila Padagis Israel Rising Salix Sun Pharmaceutical Industries, Inc. Takeda Teva Pharmaceuticals USA, Inc. Viatris Specialty Zydus Zydus Lifesciences -
GelatinDiffers by manufacturer
18 of 59 checked products list gelatin; 41 do not. See the products
Does not list it Actavis Allergan American Health Packaging Amneal Amring ANI AvKARE Bryant Ranch Prepack Camber Chartwell RX Encube Ethicals Golden State Medical Supply KLM Laboratories Private Lannett Major NorthStar RxLLC Nuvaila Padagis Israel Rising Salix Sun Pharmaceutical Industries, Inc. Takeda Teva Pharmaceuticals, Inc. Teva Pharmaceuticals USA, Inc. Viatris Specialty Zydus Zydus Lifesciences
Also listed by some products: Starch (source not stated) 7 of 59 Corn 6 of 59 Sulfites 7 of 59 Titanium dioxide 39 of 59 Carmine or shellac 29 of 59 Propylene glycol 20 of 59 PEG or polysorbate 22 of 59 Aspartame 2 of 59 Sugar 14 of 59
7 products list starch without a stated source. Most pharmaceutical starch is corn, but the label does not say, so it is flagged on its own.
Find a version without it
Every current Mesalamine product and what its label lists
| Product | Lists | Inactive ingredients on the label |
|---|---|---|
| Actavis Pharma, Inc. 2 products | ||
| 1.2 g delayed-release tabletNDC 00591-2245-22 | Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 19 ingredientsAMMONIA, COPOVIDONE K25-31, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE K90, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1000 mg rectal suppositoryNDC 00472-1915-30 | None of these listed |
Show 1 ingredientFAT, HARD |
| Alembic Pharmaceuticals Inc. 1 product | ||
| 0.375 g extended-release capsuleNDC 62332-0724-35 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 16 ingredientsETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FD&C RED NO. 40, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST), HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Alembic Pharmaceuticals Limited 1 product | ||
| 0.375 g extended-release capsuleNDC 46708-0724-35 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 16 ingredientsETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FD&C RED NO. 40, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST), HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Allergan, Inc. 1 product | ||
| 1000 mg rectal suppositoryNDC 58914-0501-33 | None of these listed |
Show 1 ingredientFAT, HARD |
| American Health Packaging 4 products | ||
| 400 mg delayed-release capsuleNDC 60687-0556-32 | Lactose Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsAMMONIA, DIBUTYL SEBACATE, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, HYPROMELLOSE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 6000, POTASSIUM HYDROXIDE, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC |
| 1.2 g delayed-release tabletNDC 60687-0397-25 | Still being read | Not read yet |
| 800 mg delayed-release tabletNDC 60687-0408-25 | Titanium dioxide Carmine or shellac Propylene glycol |
Show 16 ingredientsACETYLTRIBUTYL CITRATE, AMMONIA, BUTYL ALCOHOL, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, METHACRYLIC ACID, MICROCRYSTALLINE CELLULOSE, POVIDONE, UNSPECIFIED, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE |
| 0.375 g extended-release capsuleNDC 60687-0650-32 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 21 ingredientsETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2208 (4000 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, NONOXYNOL-100, POLYETHYLENE GLYCOL 400, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE, VANILLIN |
| Amneal Pharmaceuticals LLC 1 product | ||
| 800 mg delayed-release tabletNDC 65162-0360-18 | Lactose Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsDIBUTYL SEBACATE, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSES, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER, POLYETHYLENE GLYCOL, UNSPECIFIED, POVIDONE, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC |
| Amring Pharmaceuticals Inc. 1 product | ||
| 1000 mg rectal suppositoryNDC 69918-0560-30 | None of these listed |
Show 1 ingredientFAT, HARD |
| ANI Pharmaceuticals, Inc. 2 products | ||
| 4 g/60 mL enemaNDC 62559-0420-07 | Sulfites Sugar (sucrose, dextrose) |
Show 8 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED), EDETATE DISODIUM, PETROLATUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| 4 g/60 mL enemaNDC 70954-0301-20 | Sulfites |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| Ascend Laboratories, LLC 1 product | ||
| 0.375 g extended-release capsuleNDC 67877-0717-05 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Polyethylene glycol or polysorbate |
Show 19 ingredientsETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2208 (4000 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, NONOXYNOL-100, POLYETHYLENE GLYCOL 400, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE, VANILLIN |
| Aurobindo Pharma Limited 1 product | ||
| 0.375 g extended-release capsuleNDC 59651-0397-08 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 18 ingredientsD&C RED NO. 22, DIMETHICONE, ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE 101, NONOXYNOL-100, POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| AvKARE 1 product | ||
| 800 mg delayed-release tabletNDC 42291-0489-18 | Lactose Starch, source not stated Synthetic dyes Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 20 ingredientsBUTYL ALCOHOL, DIBUTYL SEBACATE, FD&C RED NO. 40, FD&C YELLOW NO. 6 ALUMINUM LAKE, FERRIC OXIDE RED, ISOPROPYL ALCOHOL, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 6000, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE |
| AvPAK 1 product | ||
| 0.375 g extended-release capsuleNDC 50268-0577-15 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Polyethylene glycol or polysorbate |
Show 19 ingredientsETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW), FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2208 (4000 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, NONOXYNOL-100, POLYETHYLENE GLYCOL 400, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE, VANILLIN |
| Bryant Ranch Prepack 7 products | ||
| 1.2 g delayed-release tabletNDC 72162-2213-02 | Starch, source not stated Titanium dioxide Polyethylene glycol or polysorbate |
Show 15 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE 2910 (15 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1.2 g delayed-release tabletNDC 72162-2231-02 | Still being read | Not read yet |
| 4 g/60 mL enemaNDC 72162-2302-02 | Sulfites Sugar (sucrose, dextrose) |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| kitsNDC 63629-8678-01 | Still being read | Not read yet |
| kitsNDC 63629-8679-01 | Still being read | Not read yet |
| 1000 mg rectal suppositoryNDC 72162-1804-01 | None of these listed |
Show 1 ingredientHARD FAT |
| 1000 mg rectal suppositoryNDC 63629-2397-01 | None of these listed |
Show 1 ingredientHARD FAT |
| Camber Pharmaceuticals, Inc. 3 products | ||
| 1.2 g delayed-release tabletNDC 31722-0043-05 | Starch, source not stated Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsAMMONIA, CERIC OXIDE, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE 102, POLYETHYLENE GLYCOL 6000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 375 mg extended-release capsuleNDC 31722-0489-12 | Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 19 ingredientsAMMONIA, DIMETHICONE, UNSPECIFIED, ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 40% AQUEOUS), FERRIC OXIDE RED, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE 101, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1000 mg rectal suppositoryNDC 31722-0005-30 | None of these listed |
Show 1 ingredientHARD FAT |
| Chartwell RX, LLC 1 product | ||
| 1.2 g delayed-release tabletNDC 62135-0714-12 | Starch, source not stated Titanium dioxide Polyethylene glycol or polysorbate |
Show 15 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE 2910 (15 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Encube Ethicals, Inc. 1 product | ||
| 4 g/60 mL enemaNDC 21922-0045-47 | Sulfites Sugar (sucrose, dextrose) |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| Golden State Medical Supply, Inc. 2 products | ||
| 1.2 g delayed-release tabletNDC 51407-0900-12 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, CELLULOSE, MICROCRYSTALLINE, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSES, MAGNESIUM STEARATE, METHACRYLIC ACID, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 0.375 g extended-release capsuleNDC 51407-0976-12 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Sugar (sucrose, dextrose) |
Show 15 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, STARCH, CORN, SUCROSE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Ingenus Pharmaceuticals, LLC 1 product | ||
| 0.375 g extended-release capsuleNDC 50742-0371-12 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 12 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 2, FERROSOFERRIC OXIDE, GELATIN, HYPROMELLOSE, UNSPECIFIED, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), microcrystalline cellulose, POTASSIUM HYDROXIDE, SHELLAC, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| KLM Laboratories Private Limited 1 product | ||
| 4 g/60 mL enemaNDC 84725-0002-03 | Sulfites |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| Lannett Company Inc. 1 product | ||
| 1.2 g delayed-release tabletNDC 00527-3012-48 | Starch, source not stated Titanium dioxide Polyethylene glycol or polysorbate |
Show 15 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE 2910 (15 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Major Pharmaceuticals 1 product | ||
| 1.2 g delayed-release tabletNDC 00904-6832-04 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, METHACRYLIC ACID, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Mylan Pharmaceuticals Inc. 1 product | ||
| 0.375 g extended-release capsuleNDC 00378-1375-78 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Sugar (sucrose, dextrose) |
Show 15 ingredientsAMMONIA, ETHYLCELLULOSE, UNSPECIFIED, FD&C GREEN NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, STARCH, CORN, SUCROSE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Northstar Rx LLC. 1 product | ||
| 1000 mg rectal suppositoryNDC 16714-0245-30 | Still being read | Not read yet |
| NorthStar RxLLC 1 product | ||
| 1.2 g delayed-release tabletNDC 72603-0304-01 | Starch, source not stated Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsAMMONIA, CERIC OXIDE, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE 102, POLYETHYLENE GLYCOL 6000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Nuvaila Limited 1 product | ||
| 1.2 g delayed-release tabletNDC 84612-0175-13 | Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 6000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Oceanside Pharmaceuticals 1 product | ||
| 375 mg extended-release capsuleNDC 68682-0113-20 | Still being read | Not read yet |
| Padagis Israel Pharmaceuticals Ltd 3 products | ||
| 4 g/60 mL enemaNDC 45802-0098-28 | Sulfites Sugar (sucrose, dextrose) |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| kitsNDC 45802-0923-41 | No inactive-ingredient list on the label | No list we could read |
| kitsNDC 45802-0929-49 | Still being read | Not read yet |
| Rising Pharma Holdings, Inc. 2 products | ||
| 1000 mg rectal suppositoryNDC 16571-0246-03 | None of these listed |
Show 1 ingredientFAT, HARD |
| 1000 mg rectal suppositoryNDC 64980-0282-03 | None of these listed |
Show 1 ingredientFAT, HARD |
| Salix Pharmaceuticals, Inc. 1 product | ||
| 375 mg extended-release capsuleNDC 65649-0103-01 | Titanium dioxide Aspartame (phenylalanine) |
Show 11 ingredientsANHYDROUS CITRIC ACID, ASPARTAME, CROSPOVIDONE, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Sandoz Inc 2 products | ||
| 250 mg extended-release capsuleNDC 00781-2791-64 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Sugar (sucrose, dextrose) |
Show 17 ingredientsAMMONIA, CASTOR OIL, DIACETYLATED MONOGLYCERIDES, ETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, METHYLENE CHLORIDE, POTASSIUM HYDROXIDE, POVIDONE K90, PROPYLENE GLYCOL, SHELLAC, STEARIC ACID, SUCROSE, TALC, TITANIUM DIOXIDE |
| 500 mg extended-release capsuleNDC 00781-2793-72 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Sugar (sucrose, dextrose) |
Show 18 ingredientsAMMONIA, CASTOR OIL, DIACETYLATED MONOGLYCERIDES, ETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE 2910 (5 MPA.S), HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST), METHYLENE CHLORIDE, POTASSIUM HYDROXIDE, POVIDONE K90, PROPYLENE GLYCOL, SHELLAC, STEARIC ACID, SUCROSE, TALC, TITANIUM DIOXIDE |
| Sun Pharmaceutical Industries, Inc. 1 product | ||
| 1.2 g delayed-release tabletNDC 63304-0175-13 | Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), MAGNESIUM STEARATE, METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 6000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Sun Pharmaceutical Industries Inc. 1 product | ||
| 500 mg extended-release capsuleNDC 63304-0089-13 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Sugar (sucrose, dextrose) |
Show 17 ingredientsCASTOR OIL, DIACETYLATED MONOGLYCERIDES, ETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, STARCH, CORN, STEARIC ACID, SUCROSE, TALC, TITANIUM DIOXIDE, WHITE WAX |
| Takeda Pharmaceuticals America, Inc. 4 products | ||
| 250 mg capsuleNDC 54092-0189-81 | Synthetic dyes Titanium dioxide Gelatin Sugar (sucrose, dextrose) |
Show 14 ingredientsCASTOR OIL, D&C YELLOW NO. 10, DIACETYLATED MONOGLYCERIDES, ETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C GREEN NO. 3, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, SILICON DIOXIDE, STEARIC ACID, SUCROSE, TALC, TITANIUM DIOXIDE, WHITE WAX |
| 500 mg capsuleNDC 54092-0191-12 | Synthetic dyes Titanium dioxide Gelatin Sugar (sucrose, dextrose) |
Show 12 ingredientsCASTOR OIL, DIACETYLATED MONOGLYCERIDES, ETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, SILICON DIOXIDE, STEARIC ACID, SUCROSE, TALC, TITANIUM DIOXIDE, WHITE WAX |
| 1.2 g delayed-release tabletNDC 54092-0100-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED, CARNAUBA WAX, FERRIC OXIDE RED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 6000, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, STEARIC ACID, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1.2 g delayed-release tabletNDC 54092-0476-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED, CARNAUBA WAX, FERRIC OXIDE RED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 6000, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, STEARIC ACID, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Teva Pharmaceuticals, Inc. 1 product | ||
| 800 mg delayed-release tabletNDC 00480-7750-80 | Lactose Starch, source not stated Synthetic dyes Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 20 ingredientsBUTYL ALCOHOL, DIBUTYL SEBACATE, FD&C RED NO. 40, FD&C YELLOW NO. 6 ALUMINUM LAKE, FERRIC OXIDE RED, ISOPROPYL ALCOHOL, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 6000, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A, TALC, TITANIUM DIOXIDE |
| Teva Pharmaceuticals USA, Inc. 2 products | ||
| 400 mg delayed-release capsuleNDC 00093-5907-86 | Lactose Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 16 ingredientsAMMONIA, DIBUTYL SEBACATE, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, HYPROMELLOSE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2), POLYETHYLENE GLYCOL 6000, POTASSIUM HYDROXIDE, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC |
| 375 mg extended-release capsuleNDC 00093-9224-89 | Titanium dioxide Aspartame (phenylalanine) |
Show 12 ingredientsANHYDROUS CITRIC ACID, ASPARTAME, CROSPOVIDONE, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), MICROCRYSTALLINE CELLULOSE, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Upsher-Smith Laboratories, LLC 1 product | ||
| 0.375 g extended-release capsuleNDC 00832-6056-12 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Sugar (sucrose, dextrose) |
Show 15 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, HYPROMELLOSE, UNSPECIFIED, METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), POTASSIUM HYDROXIDE, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, STARCH, CORN, SUCROSE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Viatris Specialty LLC 1 product | ||
| 4 g/60 mL enemaNDC 00037-0066-03 | Sulfites |
Show 7 ingredientsCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED), EDETATE DISODIUM, POTASSIUM ACETATE, POTASSIUM METABISULFITE, SODIUM BENZOATE, WATER, XANTHAN GUM |
| Zydus Pharmaceuticals USA Inc. 4 products | ||
| 1.2 g delayed-release tabletNDC 68382-0711-19 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, CELLULOSE, MICROCRYSTALLINE, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSES, MAGNESIUM STEARATE, METHACRYLIC ACID, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 800 mg delayed-release tabletNDC 68382-0435-28 | Titanium dioxide Carmine or shellac Propylene glycol |
Show 16 ingredientsACETYLTRIBUTYL CITRATE, AMMONIA, BUTYL ALCOHOL, CELLULOSE, MICROCRYSTALLINE, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, METHACRYLIC ACID, POVIDONE, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE |
| 0.375 g extended-release capsuleNDC 68382-0452-19 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Sugar (sucrose, dextrose) |
Show 16 ingredientsETHYLCELLULOSE (10 MPA.S), FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, HYPROMELLOSE 2910 (5 MPA.S), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SODIUM LAURYL SULFATE, STARCH, CORN, SUCROSE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE, WATER |
| 1000 mg rectal suppositoryNDC 70710-1302-07 | None of these listed |
Show 1 ingredientFAT, HARD |
| Zydus Lifesciences Limited 4 products | ||
| 1.2 g delayed-release tabletNDC 70771-1071-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsCARBOXYMETHYLCELLULOSE SODIUM, CELLULOSE, MICROCRYSTALLINE, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSES, MAGNESIUM STEARATE, METHACRYLIC ACID, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 800 mg delayed-release tabletNDC 70771-1110-04 | Titanium dioxide Carmine or shellac Propylene glycol |
Show 16 ingredientsACETYLTRIBUTYL CITRATE, AMMONIA, BUTYL ALCOHOL, CELLULOSE, MICROCRYSTALLINE, FERRIC OXIDE RED, FERROSOFERRIC OXIDE, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, METHACRYLIC ACID, POVIDONE, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO, TALC, TITANIUM DIOXIDE |
| 0.375 g extended-release capsuleNDC 70771-1625-07 | Corn-derived Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Sugar (sucrose, dextrose) |
Show 16 ingredientsETHYLCELLULOSE (10 MPA.S), FD&C BLUE NO. 1, FERROSOFERRIC OXIDE, GELATIN, HYPROMELLOSE 2910 (5 MPA.S), METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1), POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SODIUM LAURYL SULFATE, STARCH, CORN, SUCROSE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE, WATER |
| 1000 mg rectal suppositoryNDC 70771-1513-07 | None of these listed |
Show 1 ingredientFAT, HARD |
A product with none of these listed is not certified to be without them: the label says what the manufacturer declared, and the source of a starch or a flavor is often not stated. The companies are the FDA's labelers, which include repackagers and distributors selling another company's product under their own label. The NDC opens the product's own page, with the full label and its inactive-ingredient notes.
Mesalamine without lactose
Lactose: milk sugar; a concern with lactose intolerance or a milk allergy. 5 of 59 checked products list lactose; 54 do not.
Does not list lactose
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
Lists lactose
- American Health Packaging: 400 mg delayed-release capsule
- Amneal: 800 mg delayed-release tablet
- AvKARE: 800 mg delayed-release tablet
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
Mesalamine without synthetic dyes
Synthetic dyes: FD&C or D&C colorants and their aluminum lakes. 19 of 59 checked products list synthetic dyes; 40 do not.
Does not list synthetic dyes
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Takeda: 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
Lists synthetic dyes
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- American Health Packaging: 0.375 g extended-release capsule
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Golden State Medical Supply: 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- Mylan: 0.375 g extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 0.375 g extended-release capsule
- Zydus Lifesciences: 0.375 g extended-release capsule
Mesalamine without gelatin
Gelatin: animal-derived (usually bovine or porcine); a concern for vegetarian, kosher or halal needs. 18 of 59 checked products list gelatin; 41 do not.
Does not list gelatin
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- AvKARE: 800 mg delayed-release tablet
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Takeda: 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
Lists gelatin
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- American Health Packaging: 0.375 g extended-release capsule
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvPAK: 0.375 g extended-release capsule
- Camber: 375 mg extended-release capsule
- Golden State Medical Supply: 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- Mylan: 0.375 g extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 0.375 g extended-release capsule
- Zydus Lifesciences: 0.375 g extended-release capsule
Mesalamine without starch of unstated source
Starch, source not stated: the label says "starch" without naming corn, potato, tapioca or rice. 7 of 59 checked products list starch of unstated source; 52 do not.
Does not list starch of unstated source
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 375 mg extended-release capsule, 1000 mg rectal suppository
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Major: 1.2 g delayed-release tablet
- Mylan: 0.375 g extended-release capsule
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
Lists starch of unstated source
- AvKARE: 800 mg delayed-release tablet
- Bryant Ranch Prepack: 1.2 g delayed-release tablet
- Camber: 1.2 g delayed-release tablet
- Chartwell RX: 1.2 g delayed-release tablet
- Lannett: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
Mesalamine without corn-derived ingredients
Corn-derived: corn starch, maize or corn syrup; a concern with corn allergy. 6 of 59 checked products list corn-derived ingredients; 53 do not.
Does not list corn-derived ingredients
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
Lists corn-derived ingredients
- Golden State Medical Supply: 0.375 g extended-release capsule
- Mylan: 0.375 g extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 0.375 g extended-release capsule
- Zydus Lifesciences: 0.375 g extended-release capsule
Mesalamine without sulfites
Sulfites: metabisulfite or bisulfite preservatives; a concern with sulfite sensitivity or asthma. 7 of 59 checked products list sulfites; 52 do not.
Does not list sulfites
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
Lists sulfites
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Bryant Ranch Prepack: 4 g/60 mL enema
- Encube Ethicals: 4 g/60 mL enema
- KLM Laboratories Private: 4 g/60 mL enema
- Padagis Israel: 4 g/60 mL enema
- Viatris Specialty: 4 g/60 mL enema
Mesalamine without titanium dioxide
Titanium dioxide: A white colorant some people choose to avoid. 39 of 59 checked products list titanium dioxide; 20 do not.
Does not list titanium dioxide
- Actavis: 1000 mg rectal suppository
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Bryant Ranch Prepack: 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1000 mg rectal suppository
- Encube Ethicals: 4 g/60 mL enema
- KLM Laboratories Private: 4 g/60 mL enema
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1000 mg rectal suppository
- Zydus Lifesciences: 1000 mg rectal suppository
Lists titanium dioxide
- Actavis: 1.2 g delayed-release tablet
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- American Health Packaging: 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule
- Chartwell RX: 1.2 g delayed-release tablet
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule
Mesalamine without carmine or shellac
Carmine or shellac: insect-derived red colorant or coating glaze. 29 of 59 checked products list carmine or shellac; 30 do not.
Does not list carmine or shellac
- Actavis: 1000 mg rectal suppository
- Allergan: 1000 mg rectal suppository
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 1000 mg rectal suppository
Lists carmine or shellac
- Actavis: 1.2 g delayed-release tablet
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule
- Golden State Medical Supply: 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Zydus Lifesciences: 800 mg delayed-release tablet, 0.375 g extended-release capsule
Mesalamine without propylene glycol
Propylene glycol: A solvent in liquids and capsules; a concern in kidney disease, for infants, and at high doses. 20 of 59 checked products list propylene glycol; 39 do not.
Does not list propylene glycol
- Actavis: 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 1000 mg rectal suppository
Lists propylene glycol
- Actavis: 1.2 g delayed-release tablet
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- AvKARE: 800 mg delayed-release tablet
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
- Zydus: 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Zydus Lifesciences: 800 mg delayed-release tablet, 0.375 g extended-release capsule
Mesalamine without polyethylene glycol or polysorbate
Polyethylene glycol or polysorbate: PEG, macrogol or polysorbate; a rare cause of allergic reactions. 22 of 59 checked products list polyethylene glycol or polysorbate; 37 do not.
Does not list polyethylene glycol or polysorbate
- Actavis: 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Aurobindo: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 375 mg extended-release capsule, 1000 mg rectal suppository
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Mylan: 0.375 g extended-release capsule
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
- Zydus Lifesciences: 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
Lists polyethylene glycol or polysorbate
- Actavis: 1.2 g delayed-release tablet
- American Health Packaging: 400 mg delayed-release capsule, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Ascend: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet
- Camber: 1.2 g delayed-release tablet
- Chartwell RX: 1.2 g delayed-release tablet
- Golden State Medical Supply: 1.2 g delayed-release tablet
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Takeda: 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
- Zydus: 1.2 g delayed-release tablet
- Zydus Lifesciences: 1.2 g delayed-release tablet
Mesalamine without aspartame (phenylalanine)
Aspartame (phenylalanine): A concern with phenylketonuria (PKU). 2 of 59 checked products list aspartame (phenylalanine); 57 do not.
Does not list aspartame (phenylalanine)
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema (NDC 62559-0420-07), 4 g/60 mL enema (NDC 70954-0301-20)
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 4 g/60 mL enema, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 1.2 g delayed-release tablet, 0.375 g extended-release capsule
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- Mylan: 0.375 g extended-release capsule
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Padagis Israel: 4 g/60 mL enema
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule, 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 0.375 g extended-release capsule, 1000 mg rectal suppository
Lists aspartame (phenylalanine)
- Salix: 375 mg extended-release capsule
- Teva Pharmaceuticals USA, Inc.: 375 mg extended-release capsule
Mesalamine without sugar (sucrose or dextrose)
Sugar (sucrose, dextrose): A consideration in diabetes, mostly in liquids and chewables. 14 of 59 checked products list sugar (sucrose or dextrose); 45 do not.
Does not list sugar (sucrose or dextrose)
- Actavis: 1.2 g delayed-release tablet, 1000 mg rectal suppository
- Alembic Pharmaceuticals Inc.: 0.375 g extended-release capsule
- Alembic Pharmaceuticals Limited: 0.375 g extended-release capsule
- Allergan: 1000 mg rectal suppository
- American Health Packaging: 400 mg delayed-release capsule, 800 mg delayed-release tablet, 0.375 g extended-release capsule
- Amneal: 800 mg delayed-release tablet
- Amring: 1000 mg rectal suppository
- ANI: 4 g/60 mL enema
- Ascend: 0.375 g extended-release capsule
- Aurobindo: 0.375 g extended-release capsule
- AvKARE: 800 mg delayed-release tablet
- AvPAK: 0.375 g extended-release capsule
- Bryant Ranch Prepack: 1.2 g delayed-release tablet, 1000 mg rectal suppository (NDC 72162-1804-01), 1000 mg rectal suppository (NDC 63629-2397-01)
- Camber: 1.2 g delayed-release tablet, 375 mg extended-release capsule, 1000 mg rectal suppository
- Chartwell RX: 1.2 g delayed-release tablet
- Golden State Medical Supply: 1.2 g delayed-release tablet
- Ingenus: 0.375 g extended-release capsule
- KLM Laboratories Private: 4 g/60 mL enema
- Lannett: 1.2 g delayed-release tablet
- Major: 1.2 g delayed-release tablet
- NorthStar RxLLC: 1.2 g delayed-release tablet
- Nuvaila: 1.2 g delayed-release tablet
- Rising: 1000 mg rectal suppository (NDC 16571-0246-03), 1000 mg rectal suppository (NDC 64980-0282-03)
- Salix: 375 mg extended-release capsule
- Sun Pharmaceutical Industries, Inc.: 1.2 g delayed-release tablet
- Takeda: 1.2 g delayed-release tablet (NDC 54092-0100-01), 1.2 g delayed-release tablet (NDC 54092-0476-01)
- Teva Pharmaceuticals, Inc.: 800 mg delayed-release tablet
- Teva Pharmaceuticals USA, Inc.: 400 mg delayed-release capsule, 375 mg extended-release capsule
- Viatris Specialty: 4 g/60 mL enema
- Zydus: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
- Zydus Lifesciences: 1.2 g delayed-release tablet, 800 mg delayed-release tablet, 1000 mg rectal suppository
Lists sugar (sucrose or dextrose)
- ANI: 4 g/60 mL enema
- Bryant Ranch Prepack: 4 g/60 mL enema
- Encube Ethicals: 4 g/60 mL enema
- Golden State Medical Supply: 0.375 g extended-release capsule
- Mylan: 0.375 g extended-release capsule
- Padagis Israel: 4 g/60 mL enema
- Sandoz: 250 mg extended-release capsule, 500 mg extended-release capsule
- Sun Pharmaceutical Industries Inc.: 500 mg extended-release capsule
- Takeda: 250 mg capsule, 500 mg capsule
- Upsher-Smith: 0.375 g extended-release capsule
- Zydus: 0.375 g extended-release capsule
- Zydus Lifesciences: 0.375 g extended-release capsule
At the pharmacy counter
How to use this at the pharmacy counter
- Pick the company whose list suits you and copy the NDC from the table. Many pharmacies order from wholesalers that carry several companies' versions and can request a particular one if you ask before the prescription is filled; some buy from one contracted source only, and a few insurance plans cover only certain NDCs, so ask the pharmacist to check.
- Treat "does not list" as exactly that. The label is what the manufacturer declared; a flavor or a starch may have an unstated source, and lines change. For celiac disease or a serious allergy, ask the manufacturer's medical information line for a written statement about the lot you have.
- Check the bottle each refill. A different company usually means a different shape, color and inactive-ingredient list; the pharmacist can tell you who made it, and the two-NDC comparison shows the difference line by line.
- If you need one company's version kept constant, ask your prescriber to write that company or the NDC on the prescription and tell the pharmacy you need it held. Rules vary by state and plan, so confirm with the pharmacist.
Common questions about Mesalamine inactive ingredients
Is Mesalamine gluten-free?
Does Mesalamine contain lactose?
Does Mesalamine contain soy?
Is there a dye-free Mesalamine?
Does Mesalamine contain gelatin?
Why do the inactive ingredients differ between manufacturers?
Can my pharmacy give me a specific manufacturer's version?
How current is this list?
Sources: the products are the finished Mesalamine products in the FDA's current NDC directory (openFDA), as of October 5, 2026; each inactive-ingredient list is the manufacturer's FDA Structured Product Label via DailyMed, as our label sync last read it. The concern groups are HelloPharmacist's classification of the names the label declares. Educational information only, not medical advice; confirm with your pharmacist before relying on a list. ← Back to the Mesalamine guide